IRIS Accounts Production v24.3.0.553 10630537 director 1.3.23 28.2.24 28.2.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh106305372023-02-28106305372024-02-28106305372023-03-012024-02-28106305372022-02-28106305372022-03-012023-02-28106305372023-02-2810630537ns15:EnglandWales2023-03-012024-02-2810630537ns14:PoundSterling2023-03-012024-02-2810630537ns10:Director12023-03-012024-02-2810630537ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2810630537ns10:SmallEntities2023-03-012024-02-2810630537ns10:AuditExemptWithAccountantsReport2023-03-012024-02-2810630537ns10:SmallCompaniesRegimeForDirectorsReport2023-03-012024-02-2810630537ns10:SmallCompaniesRegimeForAccounts2023-03-012024-02-2810630537ns10:FullAccounts2023-03-012024-02-281063053712023-03-012024-02-2810630537ns10:RegisteredOffice2023-03-012024-02-2810630537ns5:CurrentFinancialInstruments2024-02-2810630537ns5:CurrentFinancialInstruments2023-02-2810630537ns5:Non-currentFinancialInstruments2024-02-2810630537ns5:Non-currentFinancialInstruments2023-02-2810630537ns5:ShareCapital2024-02-2810630537ns5:ShareCapital2023-02-2810630537ns5:RetainedEarningsAccumulatedLosses2024-02-2810630537ns5:RetainedEarningsAccumulatedLosses2023-02-2810630537ns5:NetGoodwill2023-03-012024-02-2810630537ns5:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2810630537ns5:NetGoodwill2023-02-2810630537ns5:ComputerSoftware2023-02-2810630537ns5:ComputerSoftware2023-03-012024-02-2810630537ns5:NetGoodwill2024-02-2810630537ns5:ComputerSoftware2024-02-2810630537ns5:NetGoodwill2023-02-2810630537ns5:ComputerSoftware2023-02-2810630537ns5:PlantMachinery2023-02-2810630537ns5:ComputerEquipment2023-02-2810630537ns5:PlantMachinery2023-03-012024-02-2810630537ns5:ComputerEquipment2023-03-012024-02-2810630537ns5:PlantMachinery2024-02-2810630537ns5:ComputerEquipment2024-02-2810630537ns5:PlantMachinery2023-02-2810630537ns5:ComputerEquipment2023-02-2810630537ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2810630537ns5:WithinOneYearns5:CurrentFinancialInstruments2023-02-28106305371ns10:Director12023-02-28106305371ns10:Director12022-02-28106305371ns10:Director12023-03-012024-02-28106305371ns10:Director12022-03-012023-02-28106305371ns10:Director12024-02-28106305371ns10:Director12023-02-28
REGISTERED NUMBER: 10630537 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2024

for

Youngevity Supplements Uk Ltd

Youngevity Supplements Uk Ltd (Registered number: 10630537)






Contents of the Financial Statements
for the Year Ended 28 February 2024




Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 5


Youngevity Supplements Uk Ltd

Company Information
for the Year Ended 28 February 2024







DIRECTOR: J J Smith





REGISTERED OFFICE: Kemp House
152 City Road
London
EC1V 2NX





REGISTERED NUMBER: 10630537 (England and Wales)





ACCOUNTANTS: Stewarts Accountants Limited
271 High Street
Berkhamsted
Hertfordshire
HP4 1AA

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Youngevity Supplements Uk Ltd

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Youngevity Supplements Uk Ltd for the year ended 28 February 2024 which comprise the Statement of Income and Retained Earnings, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Youngevity Supplements Uk Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Youngevity Supplements Uk Ltd and state those matters that we have agreed to state to the director of Youngevity Supplements Uk Ltd in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Youngevity Supplements Uk Ltd and its director for our work or for this report.

It is your duty to ensure that Youngevity Supplements Uk Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Youngevity Supplements Uk Ltd. You consider that Youngevity Supplements Uk Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Youngevity Supplements Uk Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Stewarts Accountants Limited
271 High Street
Berkhamsted
Hertfordshire
HP4 1AA


28 November 2024

Youngevity Supplements Uk Ltd (Registered number: 10630537)

Balance Sheet
28 February 2024

28.2.24 28.2.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 21,253 27,716
Tangible assets 5 2,632 3,511
23,885 31,227

CURRENT ASSETS
Stocks 57,694 55,553
Debtors 6 6,029 17,152
Cash at bank 22,932 15,393
86,655 88,098
CREDITORS
Amounts falling due within one year 7 80,553 64,111
NET CURRENT ASSETS 6,102 23,987
TOTAL ASSETS LESS CURRENT
LIABILITIES

29,987

55,214

CREDITORS
Amounts falling due after more than one
year

8

(29,344

)

(40,549

)

PROVISIONS FOR LIABILITIES (500 ) (667 )
NET ASSETS 143 13,998

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 141 13,996
SHAREHOLDERS' FUNDS 143 13,998

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Youngevity Supplements Uk Ltd (Registered number: 10630537)

Balance Sheet - continued
28 February 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 November 2024 and were signed by:





J J Smith - Director


Youngevity Supplements Uk Ltd (Registered number: 10630537)

Notes to the Financial Statements
for the Year Ended 28 February 2024

1. STATUTORY INFORMATION

Youngevity Supplements Uk Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts received for the sale of health supplements during the year and is stated net of Value Added Tax

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2017, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Website costs are being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each assets over its estimated useful life.

Office equipment - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Youngevity Supplements Uk Ltd (Registered number: 10630537)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Computer
Goodwill software Totals
£    £    £   
COST
At 1 March 2023
and 28 February 2024 63,381 1,250 64,631
AMORTISATION
At 1 March 2023 36,175 740 36,915
Amortisation for year 6,338 125 6,463
At 28 February 2024 42,513 865 43,378
NET BOOK VALUE
At 28 February 2024 20,868 385 21,253
At 28 February 2023 27,206 510 27,716

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 March 2023
and 28 February 2024 1,696 8,160 9,856
DEPRECIATION
At 1 March 2023 1,364 4,981 6,345
Charge for year 84 795 879
At 28 February 2024 1,448 5,776 7,224
NET BOOK VALUE
At 28 February 2024 248 2,384 2,632
At 28 February 2023 332 3,179 3,511

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.24 28.2.23
£    £   
Trade debtors 1,628 1,213
Other debtors 4,401 15,939
6,029 17,152

Youngevity Supplements Uk Ltd (Registered number: 10630537)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.24 28.2.23
£    £   
Bank loans and overdrafts 10,693 10,499
Trade creditors 21,945 17,471
Taxation and social security 20,938 18,192
Other creditors 26,977 17,949
80,553 64,111

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
28.2.24 28.2.23
£    £   
Bank loans 29,344 40,549

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2024 and 28 February 2023:

28.2.24 28.2.23
£    £   
J J Smith
Balance outstanding at start of year (8,736 ) 6,519
Amounts advanced 38,119 64,283
Amounts repaid (29,481 ) (79,538 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (98 ) (8,736 )

The director's current account balance of £98 (2023: £8,736) has no fixed date for repayment, is repayable upon demand and is non-interest bearing.